NeoCast embolization for subdural hematoma treatment
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests a newer way to treat subdural hematoma—a bleeding problem inside the brain. After surgery to drain the blood, you'll receive an additional minimally invasive procedure (middle meningeal artery embolization) using a new device called NeoCast to help prevent the bleeding from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 90 years old
- Subdural hematoma (fluid/blood layer in brain) measuring at least 10 mm thick, confirmed by imaging
- Symptoms within the last 30 days such as headache, memory problems, speech difficulty, balance issues, weakness, or seizures
- Planned for both surgery to drain the hematoma and embolization procedure within 7 days of each other
- Able to return for follow-up clinic visits
- Not pregnant (if applicable) and willing to use contraception during the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting a medical glue into a specific artery in the brain can safely treat a chronic subdural hematoma (a collection of blood on the brain's surface) or a recurrent subdural hematoma. This approach may offer a less invasive alternative to traditional surgery.
This trial studies a procedure called middle-meningeal-artery embolization, which blocks the blood supply to a chronic subdural hematoma (a slow-growing blood collection around the brain). It compares outcomes in people with one-sided versus both-sided bleeds, and aims to see if this less invasive treatment can help reduce the need for surgery or improve recovery.
This trial tests a procedure called coiling (placing tiny coils) to block the blood supply to a chronic subdural hematoma, a slow-growing blood collection around the brain. It may help reduce the need for surgery and improve recovery.
This study is a registry for people with a subdural hematoma (a blood collection on the surface of the brain) who are planning to have a procedure to block one of the arteries in the scalp. The registry will track how these patients do over time.
This trial compares a newer, less invasive treatment (embolization) with traditional surgery to treat chronic subdural hematoma (a slow bleed on the brain). It aims to see which approach works better and has fewer side effects.
This trial tests a procedure called middle meningeal artery embolization, which aims to stop the bleeding and reduce the fluid buildup from a chronic subdural hematoma. It may be an option for patients who have a hematoma at least 10mm thick and one or more risk factors such as older age, blood thinners, diabetes, or certain scan features.
Hear when a new Subdural Hematoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.